David Henry Vandorpe, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sickle Cell | 3 | 2022 | 1018 | 0.970 |
Why?
|
| Erythrocytes | 10 | 2022 | 2455 | 0.870 |
Why?
|
| Anemia, Hemolytic, Congenital | 8 | 2019 | 69 | 0.860 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2021 | 80 | 0.800 |
Why?
|
| Reticulocytes | 1 | 2022 | 290 | 0.780 |
Why?
|
| Chlorides | 17 | 2016 | 667 | 0.750 |
Why?
|
| TRPV Cation Channels | 1 | 2021 | 236 | 0.720 |
Why?
|
| Podocytes | 2 | 2022 | 396 | 0.690 |
Why?
|
| Hydrops Fetalis | 6 | 2019 | 107 | 0.660 |
Why?
|
| Antiporters | 8 | 2011 | 277 | 0.640 |
Why?
|
| Ion Channels | 8 | 2022 | 1056 | 0.630 |
Why?
|
| Cations | 5 | 2022 | 232 | 0.630 |
Why?
|
| Bicarbonates | 13 | 2016 | 313 | 0.590 |
Why?
|
| Calcium Channels | 3 | 2010 | 622 | 0.570 |
Why?
|
| Chloride-Bicarbonate Antiporters | 8 | 2011 | 103 | 0.450 |
Why?
|
| Kidney Diseases | 1 | 2022 | 2149 | 0.400 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 5 | 2012 | 153 | 0.390 |
Why?
|
| Spider Venoms | 1 | 2010 | 44 | 0.360 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 3 | 2019 | 44 | 0.360 |
Why?
|
| Kidney Tubules, Distal | 6 | 1994 | 46 | 0.360 |
Why?
|
| Membrane Transport Proteins | 5 | 2011 | 1028 | 0.360 |
Why?
|
| Anion Transport Proteins | 4 | 2016 | 142 | 0.350 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2010 | 125 | 0.350 |
Why?
|
| Oocytes | 15 | 2020 | 1187 | 0.340 |
Why?
|
| Sulfates | 8 | 2016 | 390 | 0.340 |
Why?
|
| Patch-Clamp Techniques | 12 | 2017 | 964 | 0.320 |
Why?
|
| Hydrogen-Ion Concentration | 11 | 2022 | 2557 | 0.300 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 675 | 0.290 |
Why?
|
| Kidney Tubules, Collecting | 3 | 1997 | 178 | 0.290 |
Why?
|
| Calcium | 11 | 2020 | 5756 | 0.290 |
Why?
|
| Carbon Monoxide | 1 | 2010 | 531 | 0.280 |
Why?
|
| Ion Transport | 4 | 2017 | 320 | 0.280 |
Why?
|
| Potassium | 4 | 2019 | 1336 | 0.280 |
Why?
|
| Peptides | 3 | 2010 | 4409 | 0.270 |
Why?
|
| Mutation, Missense | 5 | 2019 | 2564 | 0.260 |
Why?
|
| Membrane Potentials | 13 | 2019 | 1137 | 0.250 |
Why?
|
| Potassium Channels | 3 | 1998 | 563 | 0.240 |
Why?
|
| Xenopus | 9 | 2020 | 712 | 0.230 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 4 | 2011 | 60 | 0.220 |
Why?
|
| Permeability | 2 | 2021 | 738 | 0.210 |
Why?
|
| Suramin | 1 | 2022 | 34 | 0.210 |
Why?
|
| Probenecid | 1 | 2022 | 76 | 0.210 |
Why?
|
| Xenopus laevis | 12 | 2015 | 957 | 0.210 |
Why?
|
| Anions | 4 | 2016 | 133 | 0.190 |
Why?
|
| Oxalates | 4 | 2016 | 105 | 0.190 |
Why?
|
| Kidney Medulla | 3 | 1997 | 182 | 0.180 |
Why?
|
| Cell Membrane | 6 | 2019 | 3748 | 0.180 |
Why?
|
| Apyrase | 1 | 2022 | 364 | 0.170 |
Why?
|
| Potassium Channel Blockers | 2 | 2017 | 171 | 0.170 |
Why?
|
| Cloning, Molecular | 7 | 2011 | 4320 | 0.160 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 1998 | 49 | 0.160 |
Why?
|
| Peptide Fragments | 2 | 2002 | 5097 | 0.160 |
Why?
|
| Proteins | 3 | 2005 | 6103 | 0.160 |
Why?
|
| Pancreatic Ducts | 2 | 2011 | 328 | 0.160 |
Why?
|
| Chloride Channels | 4 | 2005 | 227 | 0.160 |
Why?
|
| Animals | 42 | 2022 | 168757 | 0.150 |
Why?
|
| Trityl Compounds | 1 | 2017 | 12 | 0.150 |
Why?
|
| Erythrocyte Membrane | 2 | 2010 | 442 | 0.150 |
Why?
|
| HEK293 Cells | 3 | 2022 | 4204 | 0.150 |
Why?
|
| Sodium | 5 | 2013 | 1623 | 0.150 |
Why?
|
| Osmotic Fragility | 4 | 2019 | 37 | 0.140 |
Why?
|
| Mice | 19 | 2022 | 81183 | 0.140 |
Why?
|
| Nucleotides, Cyclic | 1 | 1997 | 81 | 0.140 |
Why?
|
| Alkalosis | 3 | 1994 | 54 | 0.140 |
Why?
|
| Aplysia | 2 | 1994 | 41 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 2025 | 0.130 |
Why?
|
| Acetamides | 1 | 2017 | 249 | 0.130 |
Why?
|
| Molecular Sequence Data | 11 | 2015 | 18111 | 0.130 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2010 | 437 | 0.130 |
Why?
|
| Ketamine | 1 | 2020 | 500 | 0.120 |
Why?
|
| Ammonium Chloride | 3 | 1994 | 74 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 6 | 2015 | 3846 | 0.120 |
Why?
|
| Neurons, Afferent | 2 | 1994 | 506 | 0.120 |
Why?
|
| Glucuronosyltransferase | 1 | 2014 | 128 | 0.120 |
Why?
|
| Oxalic Acid | 2 | 2010 | 20 | 0.120 |
Why?
|
| Mice, Transgenic | 3 | 2022 | 9734 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2021 | 2751 | 0.120 |
Why?
|
| Mutation | 9 | 2016 | 29786 | 0.110 |
Why?
|
| Apolipoproteins | 1 | 2015 | 317 | 0.110 |
Why?
|
| TRPP Cation Channels | 3 | 2005 | 176 | 0.110 |
Why?
|
| DNA, Complementary | 4 | 2007 | 2050 | 0.110 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 2 | 2005 | 168 | 0.110 |
Why?
|
| Ion Channel Gating | 4 | 2005 | 437 | 0.100 |
Why?
|
| Acidosis | 2 | 1994 | 270 | 0.100 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2012 | 192 | 0.100 |
Why?
|
| Amino Acid Sequence | 8 | 2015 | 13815 | 0.100 |
Why?
|
| Lipoproteins, HDL | 1 | 2015 | 638 | 0.100 |
Why?
|
| Neuropeptides | 2 | 1994 | 942 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2021 | 14557 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 2012 | 3768 | 0.090 |
Why?
|
| Biological Transport | 6 | 2016 | 2118 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2022 | 19229 | 0.090 |
Why?
|
| Amphibians | 1 | 2009 | 30 | 0.090 |
Why?
|
| Dipyridamole | 1 | 2010 | 145 | 0.090 |
Why?
|
| Kidney Tubules | 2 | 1990 | 488 | 0.090 |
Why?
|
| Hyperkalemia | 1 | 2011 | 218 | 0.090 |
Why?
|
| Absorption | 5 | 1995 | 248 | 0.080 |
Why?
|
| Chlorine | 2 | 2005 | 50 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1434 | 0.080 |
Why?
|
| Membrane Proteins | 4 | 2019 | 7880 | 0.080 |
Why?
|
| Clotrimazole | 2 | 1998 | 77 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2014 | 1366 | 0.080 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1998 | 189 | 0.080 |
Why?
|
| Heterozygote | 4 | 2017 | 2804 | 0.070 |
Why?
|
| Humans | 28 | 2022 | 744343 | 0.070 |
Why?
|
| Rats, Inbred Strains | 5 | 1991 | 2186 | 0.070 |
Why?
|
| Nephrolithiasis | 1 | 2008 | 110 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2011 | 1124 | 0.070 |
Why?
|
| Sharks | 1 | 2005 | 22 | 0.070 |
Why?
|
| Glycosylation | 2 | 2019 | 1126 | 0.070 |
Why?
|
| Sterols | 1 | 2005 | 63 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 18029 | 0.070 |
Why?
|
| Erythrocyte Indices | 2 | 2019 | 146 | 0.070 |
Why?
|
| Amiloride | 4 | 2001 | 121 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 3617 | 0.060 |
Why?
|
| FMRFamide | 2 | 1994 | 11 | 0.060 |
Why?
|
| Invertebrate Hormones | 2 | 1994 | 26 | 0.060 |
Why?
|
| Macrolides | 2 | 1994 | 201 | 0.060 |
Why?
|
| Kinetics | 4 | 2011 | 6473 | 0.060 |
Why?
|
| Fasting | 2 | 1994 | 1593 | 0.060 |
Why?
|
| Ionophores | 3 | 2011 | 108 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1676 | 0.050 |
Why?
|
| Biological Transport, Active | 2 | 2005 | 349 | 0.050 |
Why?
|
| Cations, Divalent | 1 | 2002 | 166 | 0.050 |
Why?
|
| Mesylates | 2 | 2011 | 36 | 0.050 |
Why?
|
| Electric Conductivity | 2 | 2008 | 411 | 0.050 |
Why?
|
| Cytoplasm | 2 | 2005 | 1539 | 0.050 |
Why?
|
| Pedigree | 3 | 2014 | 4644 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2020 | 23403 | 0.050 |
Why?
|
| Cystitis | 1 | 2020 | 93 | 0.050 |
Why?
|
| Ouabain | 2 | 2011 | 264 | 0.050 |
Why?
|
| Cell Line | 5 | 2005 | 15997 | 0.040 |
Why?
|
| RNA, Complementary | 3 | 2005 | 45 | 0.040 |
Why?
|
| Microscopy, Confocal | 3 | 2011 | 1970 | 0.040 |
Why?
|
| Hypotonic Solutions | 1 | 1998 | 49 | 0.040 |
Why?
|
| Calcium Channels, L-Type | 1 | 2020 | 240 | 0.040 |
Why?
|
| Friend murine leukemia virus | 1 | 1998 | 65 | 0.040 |
Why?
|
| Zebrafish | 2 | 2007 | 2994 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2002 | 690 | 0.040 |
Why?
|
| Protein Kinase C | 2 | 2016 | 1227 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 2002 | 582 | 0.040 |
Why?
|
| Transfection | 3 | 2013 | 5892 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2009 | 4186 | 0.040 |
Why?
|
| Guinea Pigs | 2 | 2011 | 1386 | 0.040 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2019 | 171 | 0.040 |
Why?
|
| Erythroid Precursor Cells | 1 | 1998 | 218 | 0.040 |
Why?
|
| Erythrocyte Deformability | 1 | 2017 | 56 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2007 | 1832 | 0.040 |
Why?
|
| Cyclic AMP | 2 | 2004 | 1472 | 0.040 |
Why?
|
| Diltiazem | 1 | 1997 | 133 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1285 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2011 | 1791 | 0.030 |
Why?
|
| Cell Size | 1 | 1998 | 643 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2002 | 3772 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2020 | 934 | 0.030 |
Why?
|
| Thiosulfates | 1 | 2016 | 52 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2013 | 2839 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2866 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 1997 | 409 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2007 | 4217 | 0.030 |
Why?
|
| Rats | 8 | 1997 | 24260 | 0.030 |
Why?
|
| Arginine Vasopressin | 1 | 1995 | 130 | 0.030 |
Why?
|
| Antifungal Agents | 2 | 1997 | 730 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 427 | 0.030 |
Why?
|
| Species Specificity | 2 | 2011 | 2478 | 0.030 |
Why?
|
| Desoxycorticosterone | 2 | 1991 | 50 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2020 | 895 | 0.030 |
Why?
|
| Sodium Channels | 1 | 1997 | 349 | 0.030 |
Why?
|
| Phenotype | 4 | 2019 | 16365 | 0.030 |
Why?
|
| Ligands | 1 | 2002 | 3282 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2005 | 13033 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2019 | 721 | 0.030 |
Why?
|
| Models, Biological | 4 | 2013 | 9583 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2002 | 2126 | 0.030 |
Why?
|
| Acclimatization | 1 | 1994 | 103 | 0.030 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1994 | 32 | 0.030 |
Why?
|
| Tetraethylammonium | 1 | 1994 | 58 | 0.030 |
Why?
|
| Ganglia, Invertebrate | 1 | 1994 | 24 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 3848 | 0.030 |
Why?
|
| Perfusion | 4 | 1994 | 1360 | 0.030 |
Why?
|
| Cations, Monovalent | 1 | 2013 | 25 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2020 | 1172 | 0.030 |
Why?
|
| Adult Children | 1 | 2014 | 100 | 0.030 |
Why?
|
| Cell Death | 1 | 2019 | 1706 | 0.030 |
Why?
|
| Magnesium | 1 | 1997 | 813 | 0.030 |
Why?
|
| Clone Cells | 1 | 1997 | 1692 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 6314 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 2 | 2007 | 895 | 0.030 |
Why?
|
| Cell Count | 1 | 2017 | 1856 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2002 | 4217 | 0.030 |
Why?
|
| Mathematics | 1 | 1994 | 728 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17446 | 0.030 |
Why?
|
| Ganglia | 1 | 1992 | 89 | 0.030 |
Why?
|
| Goiter, Nodular | 1 | 2011 | 24 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 1992 | 203 | 0.030 |
Why?
|
| Phorbol Esters | 1 | 2011 | 111 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1375 | 0.020 |
Why?
|
| Membrane Transport Modulators | 1 | 2011 | 24 | 0.020 |
Why?
|
| Nystatin | 1 | 2011 | 23 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2011 | 123 | 0.020 |
Why?
|
| Rubidium | 1 | 2011 | 133 | 0.020 |
Why?
|
| Ions | 1 | 2012 | 265 | 0.020 |
Why?
|
| Electrolytes | 1 | 1991 | 282 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2011 | 5179 | 0.020 |
Why?
|
| Kidney | 2 | 2020 | 7186 | 0.020 |
Why?
|
| Methylamines | 1 | 2011 | 123 | 0.020 |
Why?
|
| Cecum | 1 | 2010 | 237 | 0.020 |
Why?
|
| Urine | 1 | 1991 | 370 | 0.020 |
Why?
|
| Rubidium Radioisotopes | 1 | 2009 | 85 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 1990 | 185 | 0.020 |
Why?
|
| Bumetanide | 1 | 2009 | 95 | 0.020 |
Why?
|
| Ambystoma mexicanum | 1 | 2009 | 47 | 0.020 |
Why?
|
| Acetazolamide | 1 | 1989 | 100 | 0.020 |
Why?
|
| Valinomycin | 1 | 2008 | 19 | 0.020 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2009 | 135 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2012 | 810 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 1994 | 1686 | 0.020 |
Why?
|
| Transformation, Bacterial | 1 | 2007 | 78 | 0.020 |
Why?
|
| Hyperoxaluria | 1 | 2008 | 32 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 590 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2010 | 625 | 0.020 |
Why?
|
| Serotonin | 1 | 1992 | 1017 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2011 | 1266 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2014 | 1211 | 0.020 |
Why?
|
| Female | 12 | 2015 | 380194 | 0.020 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2009 | 494 | 0.020 |
Why?
|
| Dogs | 1 | 2012 | 3912 | 0.020 |
Why?
|
| Protein Binding | 1 | 2019 | 9386 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 1701 | 0.020 |
Why?
|
| Cholestanols | 1 | 2005 | 8 | 0.020 |
Why?
|
| Male | 12 | 2014 | 350118 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2011 | 3798 | 0.020 |
Why?
|
| Abdomen | 1 | 1992 | 1118 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2011 | 770 | 0.020 |
Why?
|
| Liver | 2 | 2014 | 7474 | 0.020 |
Why?
|
| Sodium Bicarbonate | 1 | 2004 | 62 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2004 | 305 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10481 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1866 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 547 | 0.020 |
Why?
|
| Biological Factors | 1 | 2005 | 164 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2005 | 499 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 2699 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2007 | 1801 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 2505 | 0.010 |
Why?
|
| Food | 1 | 1988 | 771 | 0.010 |
Why?
|
| Cysteine | 1 | 2007 | 874 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 1998 | 11483 | 0.010 |
Why?
|
| Codon | 1 | 2004 | 611 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2004 | 689 | 0.010 |
Why?
|
| Sodium Radioisotopes | 1 | 2001 | 6 | 0.010 |
Why?
|
| Introns | 1 | 2005 | 991 | 0.010 |
Why?
|
| Electrodes | 1 | 2004 | 619 | 0.010 |
Why?
|
| RNA Interference | 1 | 2011 | 2889 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 2001 | 93 | 0.010 |
Why?
|
| Anthracenes | 1 | 2001 | 84 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 2001 | 173 | 0.010 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2007 | 1122 | 0.010 |
Why?
|
| Serine | 1 | 2005 | 826 | 0.010 |
Why?
|
| Hydrogen | 1 | 2001 | 164 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21746 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 1682 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 4328 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 1723 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1950 | 0.010 |
Why?
|
| Tyrosine | 1 | 2005 | 1461 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 6622 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2001 | 683 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 4803 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2001 | 380 | 0.010 |
Why?
|
| Base Sequence | 1 | 2011 | 12797 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 452 | 0.010 |
Why?
|
| Exons | 1 | 2005 | 2437 | 0.010 |
Why?
|
| Animals, Newborn | 2 | 1997 | 2726 | 0.010 |
Why?
|
| Adult | 4 | 2014 | 214055 | 0.010 |
Why?
|
| Diuretics | 1 | 2001 | 592 | 0.010 |
Why?
|
| Imidazoles | 2 | 1994 | 1206 | 0.010 |
Why?
|
| Superior Cervical Ganglion | 1 | 1997 | 33 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.010 |
Why?
|
| Calcimycin | 1 | 1997 | 222 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1997 | 116 | 0.010 |
Why?
|
| Body Weight | 1 | 1988 | 4669 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1997 | 330 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 4740 | 0.010 |
Why?
|
| Solutions | 1 | 1997 | 426 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1997 | 829 | 0.010 |
Why?
|
| Stilbenes | 1 | 1997 | 156 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1995 | 107 | 0.010 |
Why?
|
| Hydrochloric Acid | 1 | 1994 | 76 | 0.010 |
Why?
|
| Receptors, Vasopressin | 1 | 1995 | 112 | 0.010 |
Why?
|
| Proton-Translocating ATPases | 1 | 1994 | 116 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 8436 | 0.010 |
Why?
|
| Anti-Ulcer Agents | 1 | 1994 | 119 | 0.010 |
Why?
|
| Acute Disease | 2 | 1994 | 7149 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 5535 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1997 | 1901 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1994 | 8301 | 0.010 |
Why?
|
| Child | 2 | 2011 | 77709 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1995 | 1308 | 0.010 |
Why?
|
| Aging | 1 | 1991 | 8664 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 15540 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 25625 | 0.010 |
Why?
|
| Oxytocin | 1 | 1995 | 394 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1994 | 2274 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 35136 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1994 | 9146 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2004 | 6544 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 41006 | 0.000 |
Why?
|
| Middle Aged | 2 | 2014 | 213383 | 0.000 |
Why?
|
| Reference Values | 1 | 1994 | 4982 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 2645 | 0.000 |
Why?
|
| Adolescent | 1 | 2014 | 85781 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 2 | 1994 | 7181 | 0.000 |
Why?
|
| Neurons | 1 | 2004 | 9338 | 0.000 |
Why?
|
| Fetus | 1 | 1991 | 1880 | 0.000 |
Why?
|
| Time Factors | 1 | 2004 | 40075 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 10943 | 0.000 |
Why?
|
| Diet | 1 | 1994 | 7939 | 0.000 |
Why?
|